tiprankstipranks
Chimeric Therapeutics Ltd. (AU:CHM)
ASX:CHM
Australian Market
Holding AU:CHM?
Track your performance easily

Chimeric Therapeutics Ltd. (CHM) Income Statement

8 Followers

Chimeric Therapeutics Ltd. Income Statement

Last quarter (Q4 2022), Chimeric Therapeutics Ltd.'s total revenue was $―. In Q4, Chimeric Therapeutics Ltd.'s net income was $―. See Chimeric Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21
Total Revenue
$ ―$ ―$ 2.65K
Cost of Revenue
$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ 2.65K
Operating Expense
$ ―$ 17.19M$ 14.85M
Operating Income
$ ―$ -17.19M$ -14.85M
Net Non Operating Interest Income Expense
$ ―$ -627.15K$ -3.23K
Other Income Expense
$ ―$ 2.08M$ -263.79K
Pretax Income
$ ―$ -15.73M$ -15.11M
Tax Provision
$ ―$ 163.72K$ 0.00
Earnings From Equity Interest Net Of Tax
$ ―$ ―$ ―
Net Income Common Stockholders
$ ―$ -15.90M$ -15.11M
Basic EPS
$ ―$ -0.04$ -0.08
Diluted EPS
$ ―$ -0.04$ -0.08
Basic Average Shares
$ ―$ 359.93M$ 188.72M
Diluted Average Shares
$ ―$ 359.93M$ 188.72M
Dividend Per Share
$ ―$ ―$ ―
Total Operating Income As Reported
$ ―$ ―$ ―
Reported Normalized Basic E P S
$ ―$ ―$ ―
Reported Normalized Diluted E P S
$ ―$ ―$ ―
Rent Expense Supplemental
$ ―$ ―$ ―
Total Expenses
$ ―$ ―$ ―
Net Income From Continuing And Discontinued Operation
$ ―$ -15.90M$ -15.11M
Normalized Income
$ ―$ -15.90M$ -15.11M
Interest Expense
$ ―$ 640.13K$ 5.88K
EBIT
$ ―$ -15.09M$ -15.11M
EBITDA
$ ―$ -14.14M$ -15.11M
Currency in USD

Chimeric Therapeutics Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis